Lancet:CT扫描致电离辐射可升高儿童罹患癌症风险

2012-06-23 高晓方 中国医学论坛报

  多国联合的一项研究表明,CT扫描所致电离辐射可升高儿童罹患白血病和脑肿瘤的风险,对于儿童,应尽可能降低CT辐射剂量。论文6月7日在线发表于《柳叶刀》(Lancet)杂志。     此项回顾性队列研究以1985~2002年间首次接受CT检查时无癌症诊断,并且年龄小于22岁的患者为受试者,通过登记系统获取癌症发病率、死亡率和从英国国民健康服务体系(NHS)注册中心失随访的数据。研究者

  多国联合的一项研究表明,CT扫描所致电离辐射可升高儿童罹患白血病和脑肿瘤的风险,对于儿童,应尽可能降低CT辐射剂量。论文6月7日在线发表于《柳叶刀》(Lancet)杂志。

 

  此项回顾性队列研究以1985~2002年间首次接受CT检查时无癌症诊断,并且年龄小于22岁的患者为受试者,通过登记系统获取癌症发病率、死亡率和从英国国民健康服务体系(NHS)注册中心失随访的数据。研究者估算每次CT扫描时脑和红骨髓辐射吸收剂量,分别于首次CT扫描后2年和5年对白血病和脑肿瘤展开随访,研究者利用泊松相对危险度模型评估白血病和脑肿瘤的超额发病率。

  结果显示,在随访期间,178604例患者中有74例被诊断为白血病,176587例患者中有135例被诊断为脑肿瘤。CT扫描辐射剂量与白血病[超额相对危险度(ERR)/毫西弗(mGy)为0.36;P=0.0097]和脑肿瘤(ERR/mGy为0.023;P<0.0001)发生风险呈正相关性。

  与接受辐射剂量小于5 mGy的患者相比,接受累积剂量至少为30 mGy患者的白血病相对危险度为3.18,接受累积剂量为50~74 mGy患者的脑肿瘤相对危险度为2.82。

  ■ 同期述评

  美国哥伦比亚大学医学中心爱因斯坦(Einstein)博士:十余年前一项里程碑式的研究提示儿科CT扫描所致辐射可引发显著的超额癌症死亡,但诸多医生认为CT扫描相关性的癌症风险仅具有推测性证据,并且至今尚无流行病学研究确切显示儿童或成人期医学影像学检查造成的辐射与癌症发病率升高相关。

  此项研究有助于平息CT扫描所致风险是否真实的争论。目前至少有12个小组计划或正在对儿童人群展开研究;澳大利亚和加拿大的大样本研究将在1~2年内得出结果。这些研究将提供更为坚实的证据基础,并将深化我们对低剂量辐射诱导癌症的认识。

  研究表明,20%~50%的CT扫描可被其他影像学检查方式替代或免于实施,因此对任何CT扫描均应加以论证。    

原始文献:

Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, Howe NL, Ronckers CM, Rajaraman P, Craft AW, Parker L, Berrington de González A.Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study.Lancet. 2012 Jun 7

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1827422, encodeId=b1a7182e4227d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jan 18 08:47:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662466, encodeId=72e8166246622, content=<a href='/topic/show?id=ae61e014686' target=_blank style='color:#2F92EE;'>#电离辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70146, encryptionId=ae61e014686, topicName=电离辐射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a4e25405553, createdName=ms2536978994064944, createdTime=Wed Aug 15 14:47:00 CST 2012, time=2012-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349282, encodeId=ee8b134928219, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601308, encodeId=cc79160130827, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618753, encodeId=a8b21618e5388, content=<a href='/topic/show?id=aa2e5463db' target=_blank style='color:#2F92EE;'>#CT扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5463, encryptionId=aa2e5463db, topicName=CT扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed3819951332, createdName=ms6323715314570549, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=)]
    2013-01-18 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1827422, encodeId=b1a7182e4227d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jan 18 08:47:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662466, encodeId=72e8166246622, content=<a href='/topic/show?id=ae61e014686' target=_blank style='color:#2F92EE;'>#电离辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70146, encryptionId=ae61e014686, topicName=电离辐射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a4e25405553, createdName=ms2536978994064944, createdTime=Wed Aug 15 14:47:00 CST 2012, time=2012-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349282, encodeId=ee8b134928219, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601308, encodeId=cc79160130827, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618753, encodeId=a8b21618e5388, content=<a href='/topic/show?id=aa2e5463db' target=_blank style='color:#2F92EE;'>#CT扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5463, encryptionId=aa2e5463db, topicName=CT扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed3819951332, createdName=ms6323715314570549, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1827422, encodeId=b1a7182e4227d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jan 18 08:47:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662466, encodeId=72e8166246622, content=<a href='/topic/show?id=ae61e014686' target=_blank style='color:#2F92EE;'>#电离辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70146, encryptionId=ae61e014686, topicName=电离辐射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a4e25405553, createdName=ms2536978994064944, createdTime=Wed Aug 15 14:47:00 CST 2012, time=2012-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349282, encodeId=ee8b134928219, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601308, encodeId=cc79160130827, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618753, encodeId=a8b21618e5388, content=<a href='/topic/show?id=aa2e5463db' target=_blank style='color:#2F92EE;'>#CT扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5463, encryptionId=aa2e5463db, topicName=CT扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed3819951332, createdName=ms6323715314570549, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=)]
    2012-06-25 jiyangfei
  4. [GetPortalCommentsPageByObjectIdResponse(id=1827422, encodeId=b1a7182e4227d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jan 18 08:47:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662466, encodeId=72e8166246622, content=<a href='/topic/show?id=ae61e014686' target=_blank style='color:#2F92EE;'>#电离辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70146, encryptionId=ae61e014686, topicName=电离辐射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a4e25405553, createdName=ms2536978994064944, createdTime=Wed Aug 15 14:47:00 CST 2012, time=2012-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349282, encodeId=ee8b134928219, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601308, encodeId=cc79160130827, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618753, encodeId=a8b21618e5388, content=<a href='/topic/show?id=aa2e5463db' target=_blank style='color:#2F92EE;'>#CT扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5463, encryptionId=aa2e5463db, topicName=CT扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed3819951332, createdName=ms6323715314570549, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=)]
    2012-06-25 lq0307
  5. [GetPortalCommentsPageByObjectIdResponse(id=1827422, encodeId=b1a7182e4227d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jan 18 08:47:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662466, encodeId=72e8166246622, content=<a href='/topic/show?id=ae61e014686' target=_blank style='color:#2F92EE;'>#电离辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70146, encryptionId=ae61e014686, topicName=电离辐射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a4e25405553, createdName=ms2536978994064944, createdTime=Wed Aug 15 14:47:00 CST 2012, time=2012-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349282, encodeId=ee8b134928219, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601308, encodeId=cc79160130827, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618753, encodeId=a8b21618e5388, content=<a href='/topic/show?id=aa2e5463db' target=_blank style='color:#2F92EE;'>#CT扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5463, encryptionId=aa2e5463db, topicName=CT扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed3819951332, createdName=ms6323715314570549, createdTime=Mon Jun 25 11:47:00 CST 2012, time=2012-06-25, status=1, ipAttribution=)]

相关资讯

Lancet:沙丁胺醇增加ARDS患者死亡率

英国华威大学的Fang Gao Smith博士等近日在《柳叶刀》(The Lancet)杂志发表文章称,沙丁胺醇可增加急性呼吸窘迫综合症(ARDS)的死亡率。 这项已经停止的名为BALTI-2的临床试验称,在气管插管和机械通气的患者中,静脉输注沙丁胺醇组28天死亡率为34%,高于安慰机组的23%。分析结果表明,每9.2名使用β2受体阻滞剂的ARDS患者,将有一名患者因用药而死亡。 此前,名为B

Lancet:新药GPR40激动剂TAK-875可有效控制血糖

最新研究表明,TAK-875是治疗2型糖尿病的一种新药物,其改善血糖控制效果与格列美脲相似,但引起低血糖的风险明显低于后者。该药的2期随机试验的结果发表于2月24日《柳叶刀》(Lancet)。 2型糖尿病是最常见的糖尿病类型。目前美国约有1.5亿人患有糖尿病,其中90%是2型糖尿病。该病主要是由于机体对胰岛素的反应降低,从而导致血糖升高和各种慢性疾病。2型糖尿病患者中大约只有1/2能将血糖控制在

Lancet:耳鸣有新的有效治疗方法吗?

最近,研究人员在期刊Lancet上报道了一种治疗耳鸣的创新方法,通过对492名成人耳鸣患者为期12个月的跟踪调查,详细阐明了该创新疗法的效果。 耳鸣是在没有任何外界刺激条件下所产生的异常声音感觉,因听觉机能紊乱而引起。约15%的人不同程度地患有此病,且伴有精神不集中问题、睡眠障碍、焦虑、抑郁和极度疲劳,有时重度耳鸣会严重影响患者日常生活,目前还没有治愈耳鸣的方法。 这种创新疗法是听力学家、心理

Lancet Oncol:脑瘤治疗的新遗传标记物

近日,英国诺丁汉大学研究人员发现脑癌3套遗传标记物,可能为致命的脑瘤诊断带来新的希望。 这项最新研究由Richard Grundy教授率领,发表在权威杂志Lancet Oncology最新一期上。 尽管需要新的、更有效的治疗手段,早些年也已经开展了一系列研究,但取得的成绩并不如人意。这项诺丁汉大学完成的研究旨在筛选出可用来提高癌症治疗功效和开展治疗的分子标记物。 诺丁汉大学与加拿大多伦多病童

Lancet Oncol:发现脑肿瘤的新遗传标记

       来自英国诺丁汉大学的研究人员找到了一种致死性儿童脑肿瘤的的遗传标记,有可能为开发出新诊断工具平铺道路。        这一研究成果发表在最新出版的《柳叶刀肿瘤学》(Lancet Oncology)杂志上,由诺丁汉大学儿童脑肿瘤研究中心的Richard Grundy教授和博士后研究人员Suzanne

Lancet:帕唑帕尼抗软组织肉瘤(PALETTE研究)

     《柳叶刀》(The Lancet)杂志5月16日在线发表的一项研究表明,帕唑帕尼是既往化疗后转移的非脂肪细胞软组织肉瘤患者的新治疗选择。   该研究是一项在13个国家72个中心开展的随机、双盲、安慰剂对照Ⅲ期临床研究。   受试者为既往接受标准化疗后疾病进展的转移性软组织肉瘤患者。患者既往未接受血管生成抑制剂治疗,研究按2:1的比例随机每日1次给予其帕唑帕尼800mg或安